# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001689548-24-000048
Filing Date
2024-04-26
Accepted
2024-04-26 07:46:33
Documents
10
Period of Report
2024-06-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | prax-2024def14a.htm | DEF 14A | 693989
2 |  | an-signature.jpg | GRAPHIC | 33925
3 |  | ms-signature.jpg | GRAPHIC | 40613
4 |  | praxis-logo.jpg | GRAPHIC | 7104
5 |  | praxisprecisionmedicinesin.jpg | GRAPHIC | 199620
6 |  | praxisprecisionmedicinesina.jpg | GRAPHIC | 870114
7 |  | proxy-arrowxgraphic.jpg | GRAPHIC | 1762
8 |  | pvp1.jpg | GRAPHIC | 42505
9 |  | pvp2.jpg | GRAPHIC | 45832
10 |  | pvp3.jpg | GRAPHIC | 79395
| Complete submission text file | 0001689548-24-000048.txt |  | 2502846

Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39620 | Film No.: 24878760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)